Overview

An Extension Study to Determine Safety and Efficacy for Pediatric Patients With MPS Type IIIA Disease Who Participated in Study HGT-SAN-093.

Status:
Terminated
Trial end date:
2019-04-12
Target enrollment:
Participant gender:
Summary
This extension study will allow participants to continue receiving treatment with HGT-1410 and to initiate treatment in patients who received no-treatment in Study HGT-SAN-093, and will evaluate the long-term safety and efficacy of the study drug.
Phase:
Phase 2
Details
Lead Sponsor:
Shire